Literature DB >> 9725234

Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.

S Jüttner1, J Bernhagen, C N Metz, M Röllinghoff, R Bucala, A Gessner.   

Abstract

Macrophage migration inhibitory factor (MIF) is a product of activated T cells, anterior pituitary cells, and macrophages. MIF plays an important role in LPS-induced shock and delayed-type hypersensitivity. Furthermore, MIF exhibits a proinflammatory spectrum of action, promoting TNF-alpha production by macrophages, and counter-regulates glucocorticoid suppression of cytokine production. Here, we report that purified recombinant MIF activates murine macrophages to kill Leishmania major, with maximal effects at concentrations above 1 microg/ml. This MIF-mediated activation is specific, since it can be blocked completely by anti-MIF mAb. The MIF-mediated activation is dependent on TNF-alpha produced endogenously by macrophages, because the administration of anti-TNF-alpha antiserum markedly reduced the MIF effect. No MIF-mediated activation was observed in macrophages derived from TNF receptor p55 knockout mice, thus demonstrating the requirement of the smaller TNF receptor molecule for autocrine TNF-alpha signaling. A highly specific inhibitor of the inducible nitric oxide synthase (iNOS), L-N6-(1-iminoethyl)lysine, dihydrochloride, also inhibited the action of MIF, suggesting an important role for iNOS in the antiparasitic properties of MIF. In line with this, no MIF-mediated activation was detected analyzing macrophages derived from iNOS-deficient mice. The effect of MIF was blocked completely by the macrophage-deactivating cytokines IL-10, IL-13, and TGF-beta. Finally, the expression of MIF mRNA and protein was up-regulated in lymph nodes of mice during the first week after infection with L. major. MIF therefore represents a cytokine involved not only in the recruitment of proinflammatory cells during infection but also in the complex regulation of the antimicrobial activity of these cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725234

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis.

Authors:  Jan Carlo Delorenzi; Leonardo Freire-de-Lima; Cerli R Gattass; Deise de Andrade Costa; Liwen He; Martin E Kuehne; Elvira M B Saraiva
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.

Authors:  A R Satoskar; M Bozza; M Rodriguez Sosa; G Lin; J R David
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 4.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

5.  Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia.

Authors:  N Honma; H Koseki; T Akasaka; T Nakayama; M Taniguchi; I Serizawa; H Akahori; M Osawa; T Mikayama
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

6.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

7.  Cytokine/chemokine secretion and proteomic identification of upregulated annexin A1 from peripheral blood mononuclear cells cocultured with the liver fluke Opisthorchis viverrini.

Authors:  Nuttanan Hongsrichan; Kitti Intuyod; Porntip Pinlaor; Jarinya Khoontawad; Puangrat Yongvanit; Chaisiri Wongkham; Sittiruk Roytrakul; Somchai Pinlaor
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

8.  Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.

Authors:  N Pollak; T Sterns; B Echtenacher; D N Männel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.

Authors:  Thomas Holowka; Tiago M Castilho; Alvaro Baeza Garcia; Tiffany Sun; Diane McMahon-Pratt; Richard Bucala
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

10.  Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants.

Authors:  Eloisa Amália Vieira Ferro; José Roberto Mineo; Francesca Ietta; Nicoletta Bechi; Roberta Romagnoli; Deise Aparecida Oliveira Silva; Giuseppina Sorda; Estela Bevilacqua; Luana Ricci Paulesu
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.